Does prophylactic administration of corticosteroid reduce the risk and severity of post-ERCP pancreatitis: A randomized, prospective, multicenter study

Gastrointestinal Endoscopy

Volumn 58, Issue 1, 2003, Pages 23-29

  Sherman, Stuart ^a   Blaut, Urszula ^b   Watkins, James L ^b   Barnett, Jeffrey ^b   Freeman, Martin ^b   Geenen, Joseph ^b   Ryan, Michael ^b   Parker, Harrison ^b   Frakes, James T ^b   Fogel, Evan L ^b   Silverman, William B ^b   Dua, Kulwinder S ^b   Aliperti, Giuseppe ^b   Yakshe, Paul ^b   Uzer, Michael ^b   Jones, Whitney ^b   Goff, John ^b   Earle, Dee ^b   Temkit, M'hamed ^b   Lehman, Glen A ^b  

^a INDIANA UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; PREDNISONE;

ADULT; AGED; ARTICLE; CANNULATION; CHRONIC PANCREATITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MANOMETRY; MULTICENTER STUDY; NAUSEA; ODDI SPHINCTER; PANCREAS ACINUS; PANCREATITIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RASH; RISK ASSESSMENT; SPHINCTEROTOMY; SWEAT GLAND DISEASE; TREATMENT OUTCOME; VOMITING; AGE DISTRIBUTION; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; DOSE RESPONSE; FOLLOW UP; HOSPITALIZATION; METHODOLOGY; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PANCREAS DISEASE; PRIMARY PREVENTION; PROBABILITY; REFERENCE VALUE;

ADMINISTRATION, ORAL; ADULT; AGE DISTRIBUTION; AGED; CHI-SQUARE DISTRIBUTION; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PANCREATIC DISEASES; PANCREATITIS; PREDNISONE; PRIMARY PREVENTION; PROBABILITY; PROSPECTIVE STUDIES; REFERENCE VALUES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX;

EID: 0347442019     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1067/mge.2003.307     Document Type: Article

References (33)

1. Gottlieb K, Sherman S. ERCP and biliary endoscopic sphincterotomy-induced pancreatitis. Gastrointest Endosc Clin N Am 1998;8:87-114.
2. Freeman ML, DiSario JA, Nelson DB, Fennerty MB, Lee JG, Bjorkman DJ, et al. Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointest Endosc 2001;54:425-34.
3. Tittobello A. Diagnosis and prevention of post-ERCP pancreatitis. Endoscopy 1997;29:285-7.
4. Hogan WJ. Stenting the pancreas: is this the solution to post-ERCP pancreatitis? Gastroenterology 1998;115:1591-4.
5. Tarnasky PR, Palesch YY, Cunningham JT, Mauldin PD, Cotton PB, Hawes RH. Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction. Gastroenterology 1998;115:1518-24.
6. Poon RT, Yeung C, Lo CM, Yuen WK, Liu CL, Fan ST. Prophylactic effect of somatostatin on post-ERCP pancreatitis: a randomized controlled trial. Gastrointest Endosc 1999;49:593-8.
7. Andriulli A, Leandro G, Niro G, Mangia A, Festa V, Gambassi G, et al. Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis. Gastrointest Endosc 2000;51:1-7.
8. Cavallini G, Tittobello A, Frulloni L, Masci E, Mariana A, Di Francesco V. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. Gabexate in digestive endoscopy: Italian Group. N Engl J Med 1996;335:919-23.
9. Deviere J, Le Moine O, Van Laethem JL, Eisendrath P, Ghilain A, Severs N, et al. Interleukin 10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography. Gastroenterology 2001;120:498-505.
10. Testoni PA, Cicardi M, Bergamaschini L, Guzzoni S, Cugno M, Buizza M, et al. Infusion of C1-inhibitor plasma concentrate prevents hyperamylasemia induced by endoscopic sphincterotomy. Gastrointest Endosc 1995;42:301-5.
11. Rabenstein T, Schneider HT, Bulling D, Nicklas M, Katalinic A, Hahn EG, et al. Analysis of the risk factors associated with endoscopic sphincterotomy techniques: preliminary results of a prospective study, with emphasis on the reduced risk of acute pancreatitis with low-dose anticoagulation treatment. Endoscopy 2000;32:10-9.
12. Frick TW, Speiser DE, Bimmler D, Largiader F. Drug-induced acute pancreatitis: further criticism. Dig Dis 1993;11:113-32.
13. Underwood TW, Frye CB. Drug-induced pancreatitis. Clin Pharm 1993;12:440-8.
14. Runzi M, Layer P. Drug-associated pancreatitis: facts and fiction. Pancreas 1996;13:100-9.
15. Steinberg W, Lewis J. Steroid-induced pancreatitis: does it really exist? Gastroenterology 1981;81:799-808.
16. Kimura T, Zuidema GD, Cameron JL. Steroid administration and acute pancreatitis: studies with an isolated, perfused canine pancreas. Surgery 1979;85:520-4.
17. Studley JG, Schenk WG Jr. Pathophysiology of acute pancreatitis: evaluation of the effect and mode of action of steroids in experimental pancreatitis in dogs. Am J Surg 1982;143:761-4.
18. Lazar G Jr, Varga J, Lazar G, Duda E, Takacs T, Balogh A, et al. The effects of glucocorticoids and a glucocorticoid antagonist (RU 38486) on experimental acute pancreatitis in rat. Acta Chir Hung 1997;36:190-1.
19. Weiner GR, Geenen JE, Hogan WJ, Catalano MF. Use of corticosteroids in the prevention of post-ERCP pancreatitis. Gastrointest Endosc 1995;42:579-83.
20. Cotton PB, Lehman G, Vennes J, Geenen JE, Russell RC, Meyers WC, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc 1991;37:383-93.
21. Saluja AK, Steer MLP. Pathophysiology of pancreatitis. Role of cytokines and other mediators of inflammation. Digestion 1999;60(Suppl 1):27-33.
22. Bettinger JR, Grendell JH. Intracellular events in the pathogenesis of acute pancreatitis. Pancreas 1991;6(Suppl 1):S2-6.
23. Lasser EC, Lang JH, Lyon SG, Hamblin AE, Howard M. Glucocorticoid-induced elevations of C1-esterase inhibitor: a mechanism for protection against lethal dose range contrast challenge in rabbits. Invest Radiol 1981;16:20-3.
24. Folch E, Closa D, Prats N, Gelpi E, Rosello-Catafau J. Leukotriene generation and neutrophil infiltration after experimental acute pancreatitis. Inflammation 1998;22:83-93.
25. Norman JG. New approaches to acute pancreatitis: role of inflammatory mediators. Digestion 1999;60(Suppl 1):57-60.
26. Hirota M, Nozawa F, Okabe A, Shibata M, Beppu T, Shimada S, et al. Relationship between plasma cytokine concentration and multiple organ failure in patients with acute pancreatitis. Pancreas 2000;21:141-6.
27. Flower RJ, Blackwell GJ. Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation. Nature 1979;278:456-9.
28. Lasser EC, Berry CC, Talner LB, Santini LC, Lang EK, Gerber FH, et al. Pretreatment with corticosteroids to alleviate reactions to intravenous contrast material. N Engl J Med 1987;317:845-9.
29. Sherman S. ERCP and endoscopic sphincterotomy-induced pancreatitis. Am J Gastroenterol 1994;89:303-5.
30. Dumot JA, Conwell DL, O'Connor JB, Ferguson DR, Vargo JJ, Barnes DS, et al. Pretreatment with methylprednisolone to prevent ERCP-induced pancreatitis: a randomized, multicenter, placebo-controlled clinical trial. Am J Gastroenterol 1998;93:61-5.
31. De Palma GD, Catanzano C. Use of corticosteriods in the prevention of post-ERCP pancreatitis: results of a controlled prospective study. Am J Gastroenterol 1999;94:982-5.
32. Haber GB. Prevention of post-ERCP pancreatitis. Gastrointest Endosc 2000;51:100-3.
33. Budzynska A, Marek T, Nowak A, Kaczor R, Nowakowska-Dulawa E. A prospective, randomized, placebo-controlled trial of prednisone and allopurinol in the prevention of ERCP-induced pancreatitis. Endoscopy 2001;33:766-72.